Browsing Tag
Inc.
380 posts
Can Nike rebuild 10% margins by 2026? Inside the “Sport 2025” restructuring strategy
Nike has launched a full reset in fiscal 2025, aiming to restore double-digit EBIT margins by 2026. Find out what its “Sport 2025” strategy means for investors.
Innovent Biologics strengthens mazdutide’s global credibility as Phase 3 diabetes trials land in Nature
Innovent Biologics, Inc. lands back-to-back Nature Phase 3 wins for mazdutide in type 2 diabetes. See what it means for HKEX: 01801.
Renewal Fuels and Kepler Fusion Technologies combine to create a publicly traded fusion energy platform
Find out how Renewal Fuels’ merger with Kepler Fusion Technologies is reshaping fusion energy investment and creating a new public clean power platform.
Mark Patten named CFO of Sun Communities as company sharpens financial focus amid REIT sector challenges
Sun Communities names Mark Patten as CFO to sharpen financial strategy in 2026. Explore what this move means for capital discipline and REIT sector positioning.
Nocera bitcoin purchase: how the Nasdaq-listed company is positioning BTC within its corporate treasury
Find out how Nocera’s $2 million bitcoin purchase fits into its treasury strategy and what it signals for Nasdaq companies exploring digital assets.
From scraps to supply chain: How Amazon.com, Inc. is rethinking Whole Foods Market food waste
Amazon.com, Inc. is backing Mill Industries Inc. to cut Whole Foods Market food waste from 2027. Find out how scraps could reshape grocery supply chains.
Why Immunome’s Phase 3 varegacestat data could reshape the desmoid tumor treatment market
Immunome is set to release Phase 3 varegacestat data that could redefine its oncology strategy and valuation. Read what this catalyst really means.
Rezolute shares plunge after Phase 3 sunRIZE study fails to show significant benefit in congenital hyperinsulinism
Rezolute shares collapsed after its Phase 3 sunRIZE trial failed in congenital hyperinsulinism. Find out what went wrong and what it means for investors now.
Anixa Biosciences (NASDAQ: ANIX) moves forward as Phase 1 breast cancer vaccine data clear safety and immune hurdles
Anixa Biosciences’ breast cancer vaccine met Phase 1 safety and immune response targets. Find out how Keytruda combinations could transform care.
How Perca’s vermifiltration trial could spark a sustainability revolution in seafood processing
Find out how Perca, Inc. and seafood leaders are using earthworm-powered vermifiltration to revolutionize wastewater—and why it matters for the future.